ASAP Act Alzheimer’s Screening and Prevention Act of 2025
To amend title XVIII of the Social Security Act to provide for Medicare coverage of blood-based dementia screening tests.
The bill, known as the ASAP Act or Alzheimer’s Screening and Prevention Act of 2025, proposes to amend the Social Security Act to include Medicare coverage for blood-based tests that screen for dementia. This means that eligible individuals under Medicare would have access to these tests, which can help in early detection and prevention of Alzheimer’s disease and related dementias.
This bill would primarily affect seniors and individuals who rely on Medicare for their healthcare needs. By covering these screening tests, it aims to improve early detection, potentially leading to better management and treatment options for those diagnosed with dementia.
As of the last update on November 19, 2025, the bill has been introduced in the House and referred to the Committee on Energy and Commerce and the Committee on Ways and Means for further consideration. This marks the initial step in the legislative process, where the bill is being reviewed and possibly revised before it moves to a vote.
